XPO-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XPO-1, covering 2023-08-03 to 2023-08-03. Get the full timeline:
Most recent: Clinical Trial Update: XPO-1 in Combination With RCHOP for DH/TH Lymphoma [Phase 2]